Serine protease inhibitor Kazal type 1 mutations and pancreatitis
- PMID: 15528018
- DOI: 10.1016/j.gtc.2004.07.005
Serine protease inhibitor Kazal type 1 mutations and pancreatitis
Abstract
In summary, SPINK1 is thought to play an important role in protecting the pancreas against excessive trypsinogen activation. SPINK1 mutations are associated with the development of acute and chronic pancreatitis and have been detected in all forms of chronic pancreatitis. The strong association of mutations in the PRSS1 gene and in the SPINK1 gene with chronic pancreatitis supports the concept of intracellular trypsin activation as an initiating and extremely important step in the development of pancreatitis. The N34S mutation represents the most frequently observed pancreatitis-associated SPINK1 variant. Because the SPINK1 N34S mutation is very common in the general population, it is unlikely that this mutation alone can initiate the development of chronic pancreatitis. Thus, it rather appears that in most patients with SPINK1-associated chronic pancreatitis, this genetic variant acts as disease modifier or within a polygenic model with other yet unidentified genes or environmental cofactors. The possible interaction of mutations in the SPINK1 gene with other pancreatitis-associated susceptibility genes has to be investigated in future research efforts. The most promising candidate gene for such an interaction is the CFTR gene, because genetic alterations within the CFTR gene are also common in the general population and already have been associated with chronic pancreatitis.
Similar articles
-
Serine protease inhibitor kazal type 1 mutations and pancreatitis.Clin Lab Med. 2005 Mar;25(1):61-78. doi: 10.1016/j.cll.2004.12.005. Clin Lab Med. 2005. PMID: 15749232 Review.
-
CFTR, PRSS1 and SPINK1 mutations in the development of pancreatitis in Brazilian patients.JOP. 2003 Sep;4(5):169-77. JOP. 2003. PMID: 14526128
-
The course of genetically determined chronic pancreatitis.JOP. 2003 Jul;4(4):146-54. JOP. 2003. PMID: 12853682
-
Mutations of the serine protease inhibitor, Kazal type 1 gene, in patients with idiopathic chronic pancreatitis.Am J Gastroenterol. 2002 May;97(5):1133-7. doi: 10.1111/j.1572-0241.2002.05673.x. Am J Gastroenterol. 2002. PMID: 12014716
-
Genetic counseling for hereditary pancreatitis--the role of molecular genetics testing for the cationic trypsinogen gene, cystic fibrosis and serine protease inhibitor Kazal type 1.Gastroenterol Clin North Am. 2004 Dec;33(4):839-54. doi: 10.1016/j.gtc.2004.07.010. Gastroenterol Clin North Am. 2004. PMID: 15528021 Review.
Cited by
-
Identification of a novel kindred with familial pancreatitis and pancreatic cancer.Pancreatology. 2009;9(3):273-9. doi: 10.1159/000201553. Epub 2009 Apr 29. Pancreatology. 2009. PMID: 19407482 Free PMC article.
-
The M-ANNHEIM classification of chronic pancreatitis: introduction of a unifying classification system based on a review of previous classifications of the disease.J Gastroenterol. 2007 Feb;42(2):101-19. doi: 10.1007/s00535-006-1945-4. Epub 2007 Mar 12. J Gastroenterol. 2007. PMID: 17351799 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical